Cordelia Pemberton

Chief Financial Officer · person
Cordelia Pemberton is a chief financial officer with documented connections to multiple government contracting entities. Public records indicate involvement in lobbying activities spanning 5 years.
Connection Graph
Cordelia PembertonAgatha StonewickRoderick HalvertonOphelia NethercottWinifred Jarnagin
Facts (10)
Secondary Federal disclosure records show Cordelia Pemberton registered as a lobbyist for Catalyst Holdings on 2023-01-05.
Date: 2023-01-05 Source →
Secondary Travel expense reimbursements totalling $26,158 were made to Cordelia Pemberton by Obsidian Associates for international travel in Q4 2020.
Date: 2020-11-06 Source →
Secondary IRS Form 990 filings show Federalist Society paid $39,807 to Cordelia Pemberton for advisory services in 2021.
Date: 2021-04-02 Source →
Secondary Lobbying disclosure reports list Cordelia Pemberton as representing Apex Holdings on matters related to federal procurement policy, filed 2023-01-02.
Date: 2023-01-02 Source →
Secondary SEC filings show Cordelia Pemberton acquired 2278 shares of Federalist Society stock on 2019-04-28.
Date: 2019-04-28 Source →
Secondary Property records indicate Cordelia Pemberton co-owns a $8,318 commercial property in Arlington, VA with Leopold Inkwell, acquired 2018-09-03.
Date: 2018-09-03 Source →
Secondary Agatha Crenshall, in a deposition dated 2019-07-15, named Cordelia Pemberton as a co-signatory on a $20,843 services agreement with Palantir Technologies.
Date: 2019-07-15 Source →
Secondary Campaign finance records indicate Cordelia Pemberton contributed $29,719 to the Crenshall campaign committee on 2018-03-12.
Date: 2018-03-12 Source →
Secondary Travel expense reimbursements totalling $30,271 were made to Cordelia Pemberton by Sentinel Associates for international travel in Q2 2021.
Date: 2021-07-21 Source →
Secondary Congressional hearing transcripts from 2019-03-03 reference Cordelia Pemberton as an expert witness invited by Vanguard Ventures.
Date: 2019-03-03 Source →
Connections (4)
Agatha Stonewick
regulatory liaison
Roderick Halverton
joint venture partner
Ophelia Nethercott
policy adviser
Winifred Jarnagin
regulatory liaison